Primary Record
diosmin
- In stock
- 7,525 g
- Purity
- 99.0 %
- CAS
- 520-27-4
Compound Identifiers & Properties
- CAS
- 520-27-4
- PubChem CID
- 5281613
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
- Canonical SMILES
- COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O
Names & Synonyms
- diosmin
- Barosmin
- Diosimin
- Venosmine
- Diosmine
- Flebosten
- Diosmil
- Tovene
- Diovenor
- Daflon
- Ven-Detrex
- 520-27-4
- Litosmil
- Buchu Resin
- flebosmil
- Diosminum
- Flebavena
- Flebaven
- Hemerven
- Diosven
- Insuven
- Varinon
- Dioven
- Rioven
- Diosmina
- Veno-V
- diosmiplex
- hesperidin
- Hesperedin
- Neodiosmin
- Vasculera
- Diosmetin 7-O-rutinoside
- Barosmin;
- Diosmetin-7-O-rutinoside
- Daflon;
- Diosmin [INN]
- Resin, Buchu
- Diosmin CRS
- Ven-Detrex;
- Diosmetin 7-rutinoside
- H-chromen-4-one
- Diosmin (INN)
- Diosmin (Standard)
- Diosmin [INN:BAN]
- Daflon (TN)
- diosmetin-7-rutinose
- Diosmin (8)
- Diosmin [INN-Spanish]
- Diosmine [INN-French]
- Diosminum [INN-Latin]
- n-4-one
- Diosmin =95%
- AC1NQYQD
- Diosmin - 90%
- Diosmin, 95% 5g
- DIOSMIN 5G
- RefChem:35045
- Salinigricoflavonoloside;
- Diosmetin 7-rutinoside;
- DIOSMIN [DSC]
- Diosmetin 7-neohesperidoside
- DIOSMIN [MI]
- Diosmetin 7-b-rutinoside
- DIOSMIN [MART.]
- 7QM776WJ5N
- DIOSMIN 25G
- UNII-7QM776WJ5N
- DIOSMIN [USP-RS]
- DIOSMIN [WHO-DD]
- DTXSID4045892
- DIOSMIN 100G
- CCRIS 7915
- CHEBI:4631
- Diosmin, analytical standard
- GZSOSUNBTXMUFQ-YFAPSIMESA-N
- C28H32O15
- MFCD00009772
- DTXCID2025892
- MLS001304032
- SCHEMBL120870
- diosmetin-7-O-beta-D-rutinose
- DIOSMIN [EP MONOGRAPH]
- CHEMBL231884
- Diosmin, 85% - 5G 5g
- orb1310207
- NSC-758417
- SCHEMBL29368789
- SCHEMBL29449210
- SCHEMBL29558633
- Diosmin for Sheperd's purse CRS
- EINECS 208-289-7
- ERK5-6A22
- HY-N0178R
- C05CA03
- DIOSMIN (REFERENCE GRADE)
- BDBM153267
- GLXC-13353
- HMS2233P16
- HMS3713L08
- Diosmin for system suitability CRS
- ACT05288
- Diosmin, 98% - 25MG 25mg
- SE 4601
- ZINC4098512
- Tox21_111392
- trihydroxymethoxyflavone-O-rutinoside
- AN-873
- CD0174
- EBC-27379
- NP1929
- s2292
- AKOS015969767
- Tox21_111392_1
- 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside
- ACN-034766
- BCP9000612
- CCG-208570
- CID5281613
- DB08995
- J6.600A
- NSC 758417
- OD11673
- C28-H32-O15
- KS-00000X68
- SMP1_000183
- NCGC00095022-01
- NCGC00344564-01
- AS-13224
- BP-12422
- CAS-520-27-4
- H654
- SC-17745
- SMR000718616
- SY076010
- BCP0726000067
- AB0006700
- LS-193056
- FT-0776318
- NS00005135
- 3',5,7-trihydroxy-4'-methoxyflavone 7-rhamnoglucoside
- 3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinoside
- C10039
- D07858
- J10091
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- 520D274
- A828894
- EN300-18388399
- SR-01000799147
- 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside
- 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- Q2607865
- SR-01000799147-4
- SR-01000799147-5
- SR-01000799147-6
- 3?,5,7-Trihyd roxy-4?-methoxyflavone 7-rutinoside
- BRD-K94436377-001-10-2
- BRD-K94436377-001-11-0
- 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- Diosmin, European Pharmacopoeia (EP) Reference Standard
- 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid [IUPAC]
- 3',5,7-Trihydroxy-4'-methoxyflavone-7-(6-O-(-deoxy-alpha-L-mannopyraonsyl)-beta-D-glucopyranoside
- 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
- Diosmin, United States Pharmacopeia (USP) Reference Standard
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glycopyranosyl)oxy)-4-chromenon
- 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}-4H-CHROMEN-4-ONE
- 7-[6-O-Deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl)oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
- Diosmin for system suitability, European Pharmacopoeia (EP) Reference Standard
- 208-289-7
- 3 ,5-Dihydroxy-4 -methoxy-7-(6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)flavone
- 4h-1-benzopiran-4-ona, 7-[[6-o-(6-deoxi-?-l-mannopiranosil)-?-d-glucopiranosil]oxi]-5-hidroxi-2-(3-hidroxi-4-metoxifenil)-
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxymethyl)tetrahydropyran-2-yl)oxy-chromen-4-one
- 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(6-deoxy-?-L-mannopyranosyl)-?-D-glucopyranoside
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chrome
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl)oxan-2-yl)oxychromen-4-one
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(O6-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)chromen-4-one
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- 7-((6-O-(6-DEOXY-GA-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
- 7-((6-O-(6-Deoxy-ga-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
- 7-[(6-O-alpha-L-Rhamnopyranosyl-beta-D-glucopyranosyl)oxy]-3 ,5-dihydroxy-4 -methoxyflavone
- 7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3-hydroxy-4-methoxyphenyl)-5-hydroxy-4H-1-benzopyran-4-one
- 7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
- Diosmin; 3',5,7-Trihydroxy-4'-methoxyflavone 7-O-rutinoside; Barosmin; Buchu resin; Diosmetin 7-O-rhamnosyl(1-->6)-glucoside; Diosmetin 7-O-rutinoside; Diosmetin 7-rutinoside; Diosmil; Diosmine; Diosven; Dioven; Diovenor; Flebosmil; Flebosten; Hemerven; Insuven; Litosmil; Tovene; Varinon; Ven-Detrex; Venex 500; Venosmine; 7-[[6-O-(6-Deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',5-Dihydroxyl-4'-methoxylflavanone-7-O-alpha-L-rhamnosyl (1?6)-beta-D-glucopyranoside; 7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; Diosmetin 7-O-rhamnosyl(1?6)-glucoside; Diosmetin 7-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranoside; Diosmetin 7-beta-rutinoside